Key Financial Data Of Group

Carna Biosciences, Inc. - Filing #7726593

Concept As at
2018-03-31
2018-01-01 to
2018-03-31
2017-01-01 to
2017-12-31
As at
2017-12-31
2017-01-01 to
2017-03-31
As at
2017-03-31
Key financial data of group
Business results of group
Net sales
211,132,000 JPY
657,516,000 JPY
196,020,000 JPY
Ordinary profit (loss)
-191,334,000 JPY
-711,496,000 JPY
-113,591,000 JPY
Profit (loss) attributable to owners of parent
-194,481,000 JPY
-737,264,000 JPY
-118,646,000 JPY
Comprehensive income
-198,024,000 JPY
-738,967,000 JPY
-121,070,000 JPY
Net assets
1,179,883,000 JPY
1,377,908,000 JPY
1,681,667,000 JPY
Total assets
2,226,643,000 JPY
2,190,386,000 JPY
2,411,443,000 JPY
Basic earnings (loss) per share
-20.36
-78.53
-12.80
Diluted earnings per share
Equity-to-asset ratio
0.523 xbrli:pure
0.622 xbrli:pure
0.695 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.